Dr. Allison Ajluni, MD

Dr. Ajluni practices at 33rd Street Surgery Center LLC in Baltimore, Maryland.

Dr. Ajluni's NPI, 1912404047, was assigned on April 5, 2018. Dr. Ajluni holds Virginia license 0101272620.

Dr. Ajluni's primary practice is 33rd Street Surgery Center LLC, at 200 E 33rd St, Baltimore, MD 21218 in Baltimore City. The practice phone is (410) 554-4455.

Dr. Ajluni's primary practice is 33rd Street Surgery Center LLC in Baltimore, Maryland. Dr. Ajluni is also affiliated with MedStar Union Memorial Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Ajluni to 2 more group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ajluni practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ajluni's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Ajluni is licensed in Virginia.

CMS data shows 470 Medicare services from Dr. Ajluni across 10 procedure codes in 2024, for 185 Medicare patients. Medicare paid $30,711 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Ajluni in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 56% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ajluni's median patient age at 58, with 63% women.

In 2024, Dr. Ajluni wrote 192 Medicare Part D claims for 50 patients. 67% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $609 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Ajluni for performance year 2024, reported as part of a group. Dr. Ajluni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ajluni as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Ajluni from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 52% of the total. Novo Nordisk Inc paid the most, $32.